(Q46055999)

English

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

author name string

Josep M Grinyó

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Henrik Ekberg

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Richard D Mamelok

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Federico Oppenheimer

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Jaime Sánchez-Plumed

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Miguel Angel Gentil

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Domingo Hernandez

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Dirk R Kuypers

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

language of work or name

0 references

publication date

8 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

24

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

2269-2276

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Determinants of mycophenolic acid levels after renal transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP162

21 January 2018

Identifiers

10.1093/NDT/GFP162

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19357111

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46055999&oldid=2089634995"